睡眠時無呼吸口腔器具市場は、2025年の5億ドルから2030年までに8億ドルに成長し、予測期間中に9.8%のCAGRで成長すると予想されます。睡眠時無呼吸口腔器具市場の著名なプレーヤーには、dSomnoMed(オーストラリア)、Resmed(米国)、ProSomnus Sleep Technologies(米国)、DynaFlex(米国)、Vivos Therapeutics、Inc.(米国)、OpenAirway(カナダ)、Panthera Dental(カナダ)、Airway Management(米国)、Apnea Sciences(米国)、OravanOSA(米国)、Myerson LLC(米国)、Braebon Medical Corporation(カナダ)などがあります。
目次
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED & GEOGRAPHIC SPREAD
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.4 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key industry insights
2.1.2.3 Key data from primary sources
2.1.2.4 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
2.2.1.2 Approach 2: Presentations of companies and primary interviews
2.2.1.3 Approach 3: Primary interviews
2.2.1.4 Approach 4: Growth Forecast
2.2.1.5 CAGR projections
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 RESEARCH LIMITATIONS
2.5 RESEARCH ASSUMPTIONS
2.5.1 STUDY-RELATED ASSUMPTIONS
2.5.2 GROWTH RATE ASSUMPTIONS
2.6 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 SLEEP APNEA ORAL APPLIANCES MARKET OVERVIEW
4.2 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2025 VS. 2030
4.3 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT AND COUNTRY (2024)
4.4 GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Large pool of undiagnosed sleep apnea patients
5.2.1.2 Growing awareness associated with effects of untreated sleep apnea
5.2.1.3 Increasing usage of oral appliances among patients with mild-to-moderate sleep apnea
5.2.1.4 Entry of established companies with advanced sleep apnea oral solutions
5.2.2 RESTRAINTS
5.2.2.1 High price of customized oral appliances
5.2.2.2 Alternative therapies & medications for sleep apnea
5.2.2.3 Risks associated with oral appliance therapy for obstructive sleep apnea
5.2.3 OPPORTUNITIES
5.2.3.1 Rising demand for at-home sleep apnea tests
5.2.3.2 Increasing importance of telemedicine, mHealth, and AI
5.2.3.3 Poor compliance and low adherence associated with CPAP
5.2.4 CHALLENGES
5.2.4.1 Complex referral pathways and long waiting periods
5.3 PRICING ANALYSIS
5.3.1 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023-2025
5.3.2 AVERAGE SELLING PRICE OF SLEEP APNEA ORAL PRODUCTS, BY KEY PLAYER, 2023-2025
5.3.3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION, 2023-2025
5.4 VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.7 PORTER'S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.4 BARGAINING POWER OF BUYERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 REGULATORY ANALYSIS
5.8.1 REGULATORY LANDSCAPE
5.8.1.1 North America
5.8.1.1.1 US
5.8.1.1.1.1 Reimbursement scenario in US
5.8.1.1.2 Canada
5.8.1.2 Europe
5.8.1.3 Asia Pacific
5.8.1.3.1 Japan
5.8.1.3.2 China
5.8.1.3.3 India
5.8.1.3.4 Australia
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8.2.1 North America
5.8.2.2 Europe
5.8.2.3 Asia Pacific
5.8.2.4 Latin America
5.8.2.5 Middle East & Africa
5.9 TRADE ANALYSIS
5.9.1 TRADE ANALYSIS FOR INSTRUMENTS & APPLIANCES USED IN DENTAL SCIENCES
5.10 PATENT ANALYSIS
5.11 KEY CONFERENCES & EVENTS, 2025-2026
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 BUYING CRITERIA
5.14 IMPACT OF GENERATIVE AI ON SLEEP APNEA ORAL APPLIANCES MARKET
5.14.1 INTRODUCTION
5.14.2 MARKET POTENTIAL FOR SLEEP APNEA ORAL APPLIANCES
5.14.3 FUTURE OF GENERATIVE AI IN SLEEP APNEA ORAL APPLIANCES MARKET
5.15 INVESTMENT & FUNDING SCENARIO
5.16 TECHNOLOGY ANALYSIS
5.16.1 KEY TECHNOLOGIES
5.16.1.1 Mandibular advancement devices
5.16.2 ADJACENT TECHNOLOGIES
5.16.2.1 Daytime-nighttime appliances
5.17 END-USER PERCEPTION ANALYSIS
5.18 PURCHASE DECISION-MAKING PROCESS
5.18.1 INTRODUCTION
5.18.1.1 Need recognition
5.18.1.2 Gathering information
5.18.1.3 Evaluating alternatives
5.19 TRUMP TARIFF IMPACT ON SLEEP APNEA ORAL APPLIANCES MARKET
5.19.1 INTRODUCTION
5.19.2 KEY TARIFF RATES
6 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 MANDIBULAR ADVANCEMENT DEVICES
6.2.1 READY-MADE MANDIBULAR ADVANCEMENT DEVICES
6.2.1.1 Low cost of ready-made MADs to boost demand
6.2.2 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES
6.2.2.1 High efficacy of custom-made MADs to support market growth
6.3 TONGUE-RETAINING DEVICES
6.3.1 LOWER SUCCESS RATE OF TRDS TO HINDER MARKET GROWTH
6.4 DAYTIME-NIGHTTIME APPLIANCES
6.4.1 INCREASING COMFORT & CONVENIENCE TO FUEL MARKET
7 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE
7.1 INTRODUCTION
7.2 PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES
7.2.1 FAILURE ASSOCIATED WITH CPAP THERAPY TO BOOST DEMAND
7.3 ONLINE OTC ORAL APPLIANCES
7.3.1 LACK OF REGULATORY APPROVAL TO HINDER MARKET GROWTH
8 SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER
8.1 INTRODUCTION
8.2 MALE PATIENTS
8.2.1 INHERENT DIFFERENCES IN BODY ANATOMY TO FUEL UPTAKE
8.3 FEMALE PATIENTS
8.3.1 GROWING AWARENESS FOR IMPROVED DIAGNOSIS TO SUPPORT MARKET
9 SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP
9.1 INTRODUCTION
9.2 BELOW 40 YEARS
9.2.1 LOWER PREVALENCE OF OSA IN YOUNGER AGE GROUPS TO RESTRAIN MARKET
9.3 BETWEEN 40-60 YEARS
9.3.1 LIFESTYLE FACTORS TO CONTRIBUTE TO MARKET GROWTH
9.4 ABOVE 60 YEARS
9.4.1 AGE-ASSOCIATED DISORDERS TO SUPPORT MARKET GROWTH
10 SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL
10.1 INTRODUCTION
10.2 ONLINE PHARMACIES
10.2.1 RISING BENEFITS OFFERED BY E-COMMERCE TO PROPEL MARKET
10.3 RETAIL PHARMACIES
10.3.1 RISING ACCESSIBILITY TO WIDE RANGE OF ORAL APPLIANCES TO BOOST DEMAND
10.4 HOSPITAL PHARMACIES & DENTAL CLINICS
10.4.1 PROVISION OF MAD AND TRD DEVICES DURING ORAL PROCEDURES TO SUPPORT MARKET GROWTH
11 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER
11.1 INTRODUCTION
11.2 HOME CARE SETTINGS/INDIVIDUALS
11.2.1 GROWING PATIENT PREFERENCE FOR REMOTE OSA SERVICES TO PROPEL MARKET
11.3 HOSPITALS
11.3.1 ABILITY TO PURCHASE ADVANCED SLEEP APNEA EQUIPMENT TO DRIVE MARKET
11.4 DENTAL CLINICS
11.4.1 INCREASING ESTABLISHMENT OF PRIVATE DENTAL PRACTICES TO SUPPORT MARKET GROWTH
12 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.2 US
12.2.2.1 Favorable reimbursements and regulatory support to fuel market
12.2.3 CANADA
12.2.3.1 Increasing number of research grants for awareness of sleep disorders to drive market
12.3 EUROPE
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
12.3.2 GERMANY
12.3.2.1 High prevalence of smokers and favorable health insurance coverage to fuel market
12.3.3 UK
12.3.3.1 Rising awareness among patients and increasing number of sleep service groups to support market
12.3.4 FRANCE
12.3.4.1 Expanding geriatric population and growing awareness of early diagnosis for OSA to drive market
12.3.5 ITALY
12.3.5.1 High prevalence of obesity and CVD to fuel market
12.3.6 SPAIN
12.3.6.1 Growing focus on telemedicine and remote monitoring of OSA patients to drive market
12.3.7 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2 CHINA
12.4.2.1 Rising geriatric population and increasing cases of obesity to boost demand
12.4.3 JAPAN
12.4.3.1 Rising demand for cloud-connected sleep apnea therapeutic devices to fuel uptake
12.4.4 AUSTRALIA
12.4.4.1 Launch of technologically advanced OSA devices to aid market growth
12.4.5 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 POOR HEALTHCARE INFRASTRUCTURE AND LIMITED PUBLIC HEALTH INITIATIVES TO RESTRAIN MARKET
12.5.2 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 PRESENCE OF KEY INTERNATIONAL PLAYERS AND HIGH INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
12.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.7 GCC COUNTRIES
12.7.1 HIGH OBESITY RATE AMONG WOMEN TO SUPPORT MARKET GROWTH
12.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET
13.3 REVENUE ANALYSIS, 2022-2024
13.4 MARKET SHARE ANALYSIS, 2024
13.4.1 RANKING OF KEY MARKET PLAYERS
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Product footprint
13.5.5.4 Purchase type footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
13.6.5.1 Detailed list of key startups/SMEs
13.6.5.2 Competitive benchmarking of key startups/SMEs
13.7 COMPANY VALUATION AND FINANCIAL METRICS
13.7.1 COMPANY VALUATION
13.7.2 FINANCIAL METRICS
13.8 BRAND/PRODUCT COMPARISON
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES & APPROVALS
13.9.2 DEALS
13.9.3 EXPANSIONS
13.9.4 OTHER DEVELOPMENTS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 SOMNOMED
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 MnM view
14.1.1.3.1 Key strengths
14.1.1.3.2 Strategic choices
14.1.1.3.3 Weaknesses & competitive threats
14.1.2 RESMED
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.2.1 Deals
14.1.2.2.2 Expansions
14.1.2.3 MnM view
14.1.2.3.1 Key strengths
14.1.2.3.2 Strategic choices
14.1.2.3.3 Weaknesses & competitive threats
14.1.3 PROSOMNUS SLEEP TECHNOLOGIES
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 Recent developments
14.1.3.3.1 Deals
14.1.3.4 MnM view
14.1.3.4.1 Key strengths
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses & competitive threats
14.1.4 DYNAFLEX
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.4.3 Recent developments
14.1.4.3.1 Deals
14.1.5 VIVOS THERAPEUTICS, INC.
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 Recent developments
14.1.5.3.1 Product approvals
14.1.5.3.2 Deals
14.1.5.3.3 Expansions
14.1.5.3.4 Other developments
14.1.6 OPENAIRWAY
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.6.3 Recent developments
14.1.6.3.1 Deals
14.1.7 PANTHERA DENTAL
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.7.3 Recent developments
14.1.7.3.1 Product launches
14.1.7.3.2 Deals
14.1.7.3.3 Other developments
14.1.8 AIRWAY MANAGEMENT
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.8.3 Recent developments
14.1.8.3.1 Product launches
14.1.9 APNEA SCIENCES
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.10 ORAVANOSA
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.11 MYERSON LLC.
14.1.11.1 Business overview
14.1.11.2 Products offered
14.1.12 BRAEBON MEDICAL CORPORATION
14.1.12.1 Business overview
14.1.12.2 Products offered
14.2 OTHER PLAYERS
14.2.1 MPOWRX HEALTH & WELLNESS PRODUCTS
14.2.2 THE SNORE RELIEVER COMPANY, LLC
14.2.3 TOMED GMBH
14.2.4 THE AURUM GROUP
14.2.5 ERKODENT ENRICH KOPP GMBH
14.2.6 OSCIMED SA
14.2.7 SICAT GMBH & CO. KG
14.2.8 GLIDEWELL
14.2.9 APNOMED, INC.
14.2.10 ZQUIET
14.2.11 DREAM SYSTEMS DENTAL SLEEP LAB
14.2.12 ALIVE MEDICAL SURGICAL EQUIPMENT TRADING LLC
14.2.13 ORTHOAPNEA
14.2.14 DOC BRANDS, INC.
15 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
